Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Schemas01:42

Schemas

12.3K
A schema is a mental construct consisting of a cluster or collection of related concepts (Bartlett, 1932). There are many different types of schemata, and they all have one thing in common: schemata are a method of organizing information that allows the brain to work more efficiently. When a schema is activated, the brain makes immediate assumptions about the person or object being observed.
12.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rhabdomyolysis and Acute Kidney Injury after the New York City Marathon.

Nephron·2026
Same author

The Cutting Edge: A Clinicopathology Minireview of Immunoglobulin A Nephropathy.

Glomerular diseases·2026
Same author

Diversifying aquapheresis in critical care: An institutional experience.

Clinical nephrology·2025
Same author

Association of Collapsing Glomerulopathy with Donor Apolipoprotein L1 Risk Variants in Kidney Allografts from Black Donors.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Differing Sensitivity of Antibodies Against IgG1 Explains the Discrepancy in the Detection of IgG1: A Validation Study.

Kidney international reports·2025
Same author

Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions.

Kidney international·2025
Same journal

Urinary Soluble CD163: A Dynamic Biomarker for Monitoring Treatment Response and Relapse in IgA Nephropathy.

Kidney international reports·2026
Same journal

<i>APOL1</i> Variants, AKI, and Progression to Kidney Failure in People of African Ancestry Living with HIV.

Kidney international reports·2026
Same journal

Validation of the Standardized Outcomes in Nephrology - Life Participation (SONG-LP) Instrument in People Receiving Dialysis.

Kidney international reports·2026
Same journal

Effect of Hemodialysis With Citrate on Vascular Calcification.

Kidney international reports·2026
Same journal

Diagnostic Latency and Unmeasured Disease Severity in Male Lupus Nephritis.

Kidney international reports·2026
Same journal

Antinephrin, Antipodocin, and Anti-Kirrel1 Autoantibodies in Posttransplant Recurrent FSGS.

Kidney international reports·2026
See all related articles

Related Experiment Video

Updated: Jan 22, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

7.3K

Fibrillary Glomerulonephritis: An Update.

Jordan L Rosenstock1, Glen S Markowitz2

  • 1Division of Nephrology, Lenox Hill Hospital, Hofstra Northwell School of Medicine, New York, New York, USA.

Kidney International Reports
|July 19, 2019
PubMed
Summary
This summary is machine-generated.

Fibrillary glomerulonephritis (FGN) is a rare kidney disease. DNAJB9 protein is a key component of FGN fibrils, enabling diagnosis without electron microscopy.

Keywords:
DNAJB9fibrillary glomerulonephritis

More Related Videos

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
06:02

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants

Published on: November 28, 2025

405
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K

Related Experiment Videos

Last Updated: Jan 22, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

7.3K
Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
06:02

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants

Published on: November 28, 2025

405
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K

Area of Science:

  • Nephrology
  • Pathology
  • Molecular Biology

Background:

  • Fibrillary glomerulonephritis (FGN) is a rare glomerular disease.
  • Characterized by randomly oriented fibrillar deposits (mean diameter 20 nm).
  • Immunofluorescence shows IgG, C3, and light chain deposits, suggesting immune complex involvement.

Purpose of the Study:

  • To highlight the discovery of DNAJB9 as a major fibril component in FGN.
  • To emphasize the diagnostic utility of DNAJB9 immunohistochemistry.
  • To underscore the poor prognosis and limited treatment options for FGN.

Main Methods:

  • Immunofluorescence (IF) staining for IgG, C3, kappa, and lambda light chains.
  • Immunohistochemical staining for DNAJB9.
  • Analysis of fibrillar deposit composition and ultrastructure.

Main Results:

  • Fibrillar deposits in FGN are composed of DNAJB9.
  • DNAJB9 immunohistochemistry facilitates FGN diagnosis, obviating the need for electron microscopy.
  • FGN is associated with a poor prognosis, limited therapeutic strategies, and frequent transplant recurrence.

Conclusions:

  • DNAJB9 is a crucial diagnostic marker for FGN.
  • Accurate diagnosis of FGN is essential due to its poor prognosis.
  • Further research is needed to develop effective treatments for FGN.